financetom
Business
financetom
/
Business
/
Remy CFO says no date yet given for decision on China brandy probe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Remy CFO says no date yet given for decision on China brandy probe
Jul 24, 2024 1:53 AM

LONDON, July 24 (Reuters) - Beijing has given no

official timeframe for a decision in its anti-dumping

investigation on European Union brandy, Remy Cointreau's chief

financial officer said on Wednesday, after top cognac makers

attended a hearing on the issue last week.

China announced a probe into whether EU brandy makers were

selling their product in China at below-market rates in January,

weighing on sentiment for cognac producers like Remy as

investors fear it could result in the imposition of tariffs.

Representatives of the industry, which say the probe is

linked to a broader trade row rather than the liquor market,

attended a hearing in Beijing last week - their first chance to

defend themselves against the allegations in person.

Remy's CFO Luca Marotta told analysts on a first-quarter

sales call that China's Commerce Ministry had not given any

official communication regarding the timing of its decision

after the hearing.

The company makes some 70% of its sales from cognac, with

China one of its largest markets for the brandy, and its most

profitable.

Asked whether the group was taking any steps to mitigate the

impact of potential tariffs, such as shipping product to China

ahead of time, Marotta said it was staying calm and continuing

as normal.

"So far the investigation didn't affect consumer tastes or

the essence of the business, so we are not changing the

operation to try and anticipate, or offset, in an extraordinary

way, the... impact," he said.

He added that it was also not possible to say whether Remy

would look to pass the costs of higher tariffs onto consumers,

only that the company was prepared to react if they were

imposed.

The French cognac industry makes up almost all of China's EU

brandy imports. Other affected players include Pernod Ricard

and LVMH.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Nasdaq Considering Sale of Solovis Business
Market Chatter: Nasdaq Considering Sale of Solovis Business
May 13, 2024
11:20 AM EDT, 05/13/2024 (MT Newswires) -- Nasdaq (NDAQ) is considering a sale of it Solovis business as part of an effort to streamline its portfolio, Bloomberg reported Monday, citing people familiar with the matter. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and...
--Street Color: Apple Reportedly Plans to Sell Vision Pro Outside US
--Street Color: Apple Reportedly Plans to Sell Vision Pro Outside US
May 13, 2024
11:20 AM EDT, 05/13/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 185.90, Change: +2.85, Percent...
--Nasdaq Considering Sale of Solovis Business, Bloomberg Says
--Nasdaq Considering Sale of Solovis Business, Bloomberg Says
May 13, 2024
11:18 AM EDT, 05/13/2024 (MT Newswires) -- Price: 61.42, Change: +0.76, Percent Change: +1.25 ...
Why Is Health Care Company Fortrea Stock Diving Today?
Why Is Health Care Company Fortrea Stock Diving Today?
May 13, 2024
Fortrea Holdings Inc. ( FTRE ) shares are trading lower after the company reported soft first-quarter FY24 results and cut its revenue outlook. Revenue of $662.1 million missed the consensus of $754.6 million. As of March-end, the backlog stood at $7.4 billion, and the book-to-bill ratio for the quarter was 1.11x. Adjusted EBITDA stood at $29.5 million, a decline from $41.7 million a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved